Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Topotecan hydrochloride 4.49 mg equivalent to 4 mg topotecan Infusion, powder SmithKline Beecham Pharmaceuticals, Conshohocken, Pennsylvania, United States of America Hycamtin Meloxicam 7.5 mg Capsule, powder filled Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany Mobic Meloxicam 7.5 mg Tablet Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany Mobic Alprostadil 125 g, 250 g, 500 g, 1000 g Suppository, urethral Vivus Inc., 1200 Paco Way, Lakewood, New Jersey, United States of America and Vivus Inc., 735/745 Airport Road, Lakewood, New Jersey, United States of America Muse Neutar 21.79 mg/mL equivalent to 0.5% w/v coal tar Shampoo Faulding Pharmaceuticals, Salisbury, South Australia, Australia Neutrogena T/Gel Neutar 15 mg/mL equivalent to 0.375% w/v coal tar Solution, topical Faulding Pharmaceuticals, Salisbury, South Australia, Australia Neutrogena T/Gel Conditioner Disinfecting solution: Laurdimonium hydrolysed animal collagen 0.0085% w/v, polyxetonium chloride 0.06% w/v Protein tablet: Subtilisin 0.4 mg Daily cleaner: Miranol (imidazoline derivative) 5.1% w/v, ninol 2.2% w/v, sodium tridecyl ether (3) sulphate 0.48% w/v Combination of contact lens solutions and tablet for contact lens solution Allergan Pharmaceutical (Ireland) Limited, Westport, County Mayo, Ireland Total Care Starter Pack Dated this 14th day of July 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.